Company: CWAN
Filing Date: 2025-03-06
Form Type: S-4/A
Source: 0001193125-25-048570
Chunk: 10

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-06
Form: S-4/A
Chunk 10
---
 following addresses and telephone numbers:

| For Information Regarding Clearwater: 
 Clearwater Analytics Holdings, Inc.   
 777 W. Main                           
 Street, Suite 900                     
 Boise, ID 83702                       
 (208) 433-1200                        
 Attention: Investor Relations         |     | For Information Regarding Enfusion: 
 Enfusion, Inc.                      
 125 South Clark Street, Suite       
 750                                 
 Chicago, IL 60603                   
 (312) 253-9800                      
 Attention: Investor Relations       |

In addition, you may obtain copies of documents filed by Clearwater with the SEC by accessing Clearwater’s website at https://investors.clearwateranalytics.com/overview. You may also obtain copies of documents filed by Enfusion with the SEC by accessing Enfusion’s website at http://ir.enfusion.com. We are not incorporating the contents of the websites of the SEC, Clearwater, Enfusion or any other entity into this Proxy Statement/Prospectus. We are providing the information about how you can obtain certain documents that are incorporated by reference into this Proxy Statement/Prospectus at these websites only for your convenience. In addition, if you have questions about the Special Meeting, the Transactions, the proposals or this Proxy Statement/Prospectus, would like additional copies of the Proxy Statement/Prospectus, need to obtain proxy cards or other information related to the proxy solicitation or need help submitting a proxy or voting your shares of Enfusion Common Stock or Enfusion Class B Common Stock, you may contact Innisfree M&A Incorporated (“ Innisfree”) at the address and telephone number listed below. You will not be charged for any of these documents that you request. Innisfree M&A Incorporated Banks and Brokerage Firms Call: (212) 750-5833 Stockholders Call Toll Free: (877) 750-0637 If you would like to request any documents, please do so by , 2025, which is the date that is five business days prior to the date of the Special Meeting, in order to receive them before the Special Meeting. iii

ABOUT THIS PROXY STATEMENT/PROSPECTUS

This Proxy Statement/Prospectus, which forms part of a registration statement on Form S-4 filed with
the SEC by Clearwater, constitutes a prospectus of Clearwater under the Securities Act of 1933, as amended (the “”), with respect to Clearwater Common Stock to be issued to Enfusion Securityholders (as defined below)
p